Susan Eylward Sells Shares of IMNN
Susan Eylward, General Counsel at IMNN, sold 11,800 shares on June 29, 2026.
Key Points
- Susan Eylward, General Counsel at IMNN, sold 11,800 shares at $1.75 each on June 29, 2026, totaling $20,650.
- Shares of IMNN traded around $1.80 on Tuesday, reflecting ongoing insider activity.
- Maxim Group initiated coverage with a 'buy' rating and a $10 price target on April 17, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 29, 2026, Susan Eylward, the General Counsel and Corporate Secretary of IMNN, sold 11,800 shares of the company at an average price of $1.75 each. This transaction was not part of a pre-planned trading program and totaled $20,650.
Insider Buying and Selling at Imunon, Inc.
Susan Eylward wasn't the only insider active recently. On June 25, 2026, Douglas Vincent Faller, the Chief Medical Officer, purchased 21,896 shares at $1.72 each. On the same day, Executive Chairman Michael Tardugno and President and CEO Stacy Lindborg also bought shares, with Tardugno acquiring 42,519 shares and Lindborg 67,150 shares, both at $1.72 per share. Earlier, on June 18, 2026, Lindborg purchased another 1,803 shares at $1.82 each.
Other Institutional Activity in IMNN
Several institutional investors have also been adjusting their stakes in IMNN. Armistice Capital, LLC increased its holdings by 81,444 shares, bringing its total to 348,330 shares valued at about $1,024,090, marking a 30.5% increase. Vanguard Capital Management LLC opened a new position with 48,056 shares worth approximately $141,285. Riverview Capital Advisers, LLC maintained its position without any change, holding 34,364 shares valued at $247,765. Geode Capital Management, LLC boosted its stake by 11,989 shares, ending with 33,211 shares valued at $97,644, a 56.5% rise. Vanguard Fiduciary Trust Co also initiated a new stake, acquiring 13,269 shares worth about $39,011.
Imunon, Inc. Stock Up 12.5%
Shares of IMNN traded near $1.80 on Tuesday. The stock has seen a range of insider trading activities recently, which might interest investors tracking the company's internal sentiment.
$IMNN stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On April 17, 2026, Maxim Group initiated coverage on IMNN with a 'buy' rating and set a price target of $10. The general consensus among analysts remains optimistic, with a strong 'buy' recommendation and an average target price yet to be determined.
Bottom Line
Susan Eylward's recent sale of IMNN shares adds to the flurry of insider activity at the company. Investors often keep an eye on insider trades for potential signals about a company's future performance. While this sale was unplanned, it forms part of a broader pattern of buying and selling among IMNN's insiders. As always, it's important to remember that these trades are reported after the fact and may not reflect current holdings.
Get Imunon, Inc. alerts
New 13F filings, insider trades, and analyst moves on $IMNN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.